Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Pelita Teknologi Global Tbk. (CHIP) vs UBC Medical Indonesia Tbk. (LABS)

Pelita Teknologi Global Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Pelita Teknologi Global Tbk. dan UBC Medical Indonesia Tbk.: Pelita Teknologi Global Tbk. diperdagangkan di Rp900 (kapitalisasi pasar 725,4 M, volume 24 jam 144,8 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp161 (kapitalisasi pasar 635,95 M, volume 24 jam 1,34 jt). Perbedaan utamanya: Pelita Teknologi Global Tbk. dan UBC Medical Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (1,34 jt vs 144,8 rb). Mana yang lebih baik tergantung tujuan investasimu.

CHIPLABS
Kapitalisasi Pasar
725,4 M635,95 M
Volume
144,8 rb1,34 jt
Lot
1,45 rb13,4 rb
Perputaran
128,12 jt215,64 jt
Harga Rata-rata
884,82160,93
Nilai Transaksi
128,12 jt215,64 jt
Harga Ekuilibrium Indikatif
900161
Volume Ekuilibrium Indikatif
317

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

CHIP
Lihat detail
LABS
Lihat detail

Tentang Pelita Teknologi Global Tbk.

PT Pelita Teknologi Global Tbk (the “Company”) was established based on Notarial Deed No. 3 dated February 24, 2017 of Rumondang Nauli Hutadjulu, S.H., notary in Jakarta. The Company started itscommercial operations in 2021.

Selengkapnya di halaman CHIP

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS